Vera Therapeutics, Inc.VERANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +23.75% | +23.50% | +24.91% | +16.56% | +16.30% |
| Weighted Average Shares Diluted Growth | +23.75% | +23.50% | +24.91% | +16.56% | +16.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +119.87% | +114.39% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +109.86% | +273.51% | +45.50% | +45.62% | +40.41% |
| Book Value per Share Growth | +88.82% | +359.59% | +21.14% | +22.54% | +18.65% |
| Debt Growth | +86.00% | +1.73% | +2.26% | +46.78% | +40.62% |
| R&D Expense Growth | +150.40% | +51.91% | +67.33% | +98.14% | +39.76% |
| SG&A Expenses Growth | +67.73% | +172.58% | +115.23% | +173.23% | +184.85% |